Editorial: Cancer treatment and early detection targeting HER receptors, Volume II
Front Mol Biosci
.
2023 Jun 22:10:1229765.
doi: 10.3389/fmolb.2023.1229765.
eCollection 2023.
Authors
Xiaoqing Cai
1
,
Libing Zhang
2
,
Shengxi Chen
3
Affiliations
1
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
2
Tianjin Key Laboratory of Molecular Optoelectronic, Department of Chemistry, Tianjin University, Tianjin, China.
3
Biodesign Center for Bioenergetics, Arizona State University, Tempe, AZ, United States.
PMID:
37426424
PMCID:
PMC10325823
DOI:
10.3389/fmolb.2023.1229765
No abstract available
Keywords:
EGFR; HER family; HER2; HER3; cancer targeted therapy; early detection.
Publication types
Editorial
Grants and funding
R21 CA280458/CA/NCI NIH HHS/United States